In a 2018 mouse study of ulcerative colitis, oral [KPV](/database/kpv) reduced intestinal inflammation by 72%—comparable to the steroid prednisolone—without immunosuppressive side effects. The secret lies in its dual action: blocking NF-κB while boosting protective Treg cells.
What Is KPV?
Derived from the C-terminal fragment of α-MSH, KPV (Lys-Pro-Val) is one of the smallest bioactive peptides at just three amino acids. Researchers at the University of Florence discovered its anti-inflammatory properties in the 1990s while studying melanocortin signaling. Unlike full-length α-MSH (13 amino acids), KPV lacks hormonal activity but retains key receptor interactions.
Mechanism of Action
NF-κB Inhibition
KPV binds to MC1R and MC3R on immune cells, suppressing the NF-κB pathway. This blocks production of:
TNF-α
IL-6
IL-1β
Treg Activation
Simultaneously, KPV increases Foxp3+ regulatory T cells by 40-60% in gut-associated lymphoid tissue (GALT), creating localized immune tolerance.
Research Highlights
| Condition | Model | Dose | Duration | Result |
|---|---|---|---|---|
| Colitis | Mice (n=12/group) | 2 mg/kg oral | 7 days | 72%↓ inflammation vs control |
| Dermatitis | Human keratinocytes | 10 μM topical | 48h | IL-8 reduced by 65% |
| Sepsis | Rat (n=8/group) | 1 mg/kg IV | 24h | 58%↓ mortality rate |
Dosing Protocols
| Goal | Route | Dose | Frequency | Cycle |
|---|---|---|---|---|
| Gut inflammation | Oral | 1-2 mg/kg | 2x daily | 2-4 weeks |
| Skin conditions | Topical | 0.1-0.5% cream | Daily | As needed |
| Systemic support | SubQ | 100-200 mcg/kg | 3x weekly | 3 weeks |
Safety & Side Effects
No serious adverse events reported in studies
Theoretical risk of immunosuppression with prolonged high doses
Contraindicated with concurrent immunosuppressive drugs
How It Stacks
Pairs with [BPC-157](/database/bpc-157) for gut healing (KPV reduces inflammation while BPC stimulates repair) or [Thymosin Alpha-1](/database/thymosin-alpha-1) for immune modulation (KPV targets innate immunity, TA1 boosts adaptive).
Key Takeaways
KPV is the smallest clinically studied anti-inflammatory peptide
Works via MC receptors without hormonal effects
Oral bioavailability unique among peptides
Human safety data limited but promising
Dosing varies widely by application (topical vs systemic)
Combine with growth factors for tissue repair
---
---
Continue Your Peptide Research
🔬 Explore our peptide database — [Browse 500+ research peptide profiles](/database) with mechanisms of action, dosing protocols, and clinical evidence summaries.
🤖 Have questions? — [Ask PeptideAI](/chat), our research assistant, for personalized peptide guidance based on the latest studies.
📚 Want more guides? — [Browse all research articles](/articles) covering peptide science, comparisons, and buying guides.
Related Articles on BuyPeptidesOnline.com
Continue your research with these in-depth guides:
[BPC-157 for Gut Healing: Ulcerative Colitis, IBS, Leaky Gut and Gastrointestinal Research](/articles/bpc-157-gut-healing-ulcerative-colitis-ibs-leaky-gut)
[BPC-157 and TB-500 Blend: The Ultimate Healing Stack Protocol for Tendon, Joint and Tissue Repair](/articles/bpc-157-tb-500-blend-healing-stack-protocol)
[BPC-157 For Sale: How to Source Pure Body Protection Compound in 2026](/articles/bpc-157-for-sale-sourcing-guide-2026)
[Peptides 101: Everything a Beginner Needs to Know](/articles/peptides-101-beginner-guide)
[Where to Buy Peptides Online in 2026: The Complete Research Buyer Guide](/articles/where-to-buy-peptides-online-2026-complete-guide)